Ilodecakin

(USAN, rINN)
Synonyms: Ilodecakina; Ilodécakine; Ilodecakinum; Interleukin-10 (human clone pH15C); rhIL-10; Sch-52000.
Cyrillic synonym: Илодекакин.

Chemical information

CAS — 149824-15-7.

Profile

Interleukin-10 is one of a number of polypeptides known collectively as interleukins. It regulates the differentiation and proliferation of several immune cells including T-cells and Bcells. It is postulated that it has immunostimulant as well as immunosuppressive properties; it also has anti-inflammatory actions. Interleukin-10 is under investigation for inflammatory bowel disease, malignant neoplasms, skin disorders including psoriasis and reduction of scarring, rheumatoid arthritis, hepatitis C, and organ transplantation. Ilodecakin is a recombinant form of interleukin-10 under investigation.
1. Asadullah K, et al. Interleukin-10 therapy—review of a new approach. Pharmacol Rev 2003; 55: 241–69
2. Braat H, et al. Interleukin-10-based therapy for inflammatory bowel disease. Expert Opin Biol Ther 2003; 3: 725–31
3. Weiss E, et al. The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases. J Am Acad Dermatol 2004; 50: 657–75
4. Asadullah K, et al. Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy 2004; 3: 185–92
5. Vicari AP, Trinchieri G. Interleukin-10 in viral diseases and cancer: exiting the labyrinth? Immunol Rev 2004; 202: 223–36
6. Mocellin S, et al. Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol 2005; 78: 1043–51
7. Mege JL, et al. The two faces of interleukin 10 in human infectious diseases. Lancet Infect Dis 2006; 6: 557–69.
Published May 08, 2019.